RARE: ウルトラジェニクス・ファーマシューティカル

RARE News

• 20:33 Stocks Finish Mostly Higher on Earnings Optimism
• 15:25 Stocks Rebound on Strong Earnings and Lower Bond Yields
• 14:09 Stocks Pressured by Tech Stock Weakness and Higher Crude Oil Prices
• 13:11 Ultragenyx Settles DOJOLVI Patent Litigation With Navinta, Allowing Generic Entry Starting January 1, 2033; Or July 2033 With Pediatric Exclusivity; Similar Patent Litigation Against Other DOJOLVI Abbreviated New Drug Application Filers Related To...
• 21:31 UBS Initiates Coverage On Ultragenyx Pharmaceutical with Neutral Rating, Announces Price Target of $16
• 13:33 RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week
• 13:30 Can RARE's Approved Product Portfolio Drive Its Next Growth Phase?
• 20:44 Stocks Finish Lower Ahead of Wednesday’s CPI Report
• 08:02 Binance to Lower Leverage and Margin Tiers for Multiple USDT-Margined Perpetual Contracts
• 13:49 Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash
• 20:39 Stocks Settle Lower on Higher Bond Yields
• 15:16 Stocks Fall and Bond Yields Rise on Inflation Worries
• 14:46 Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
• 06:19 Ultragenyx Gene Therapy For MPS IIIA Clears EMA Validation, Holds PRIME And Orphan Designations, Will Fall Under EU Joint Clinical Assessment
• 16:30 Evercore ISI Group Maintains In-Line on Ultragenyx Pharmaceutical, Raises Price Target to $18
• 12:44 Barclays Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $35
• 16:30 Morgan Stanley Maintains Equal-Weight on Ultragenyx Pharmaceutical, Raises Price Target to $20
• 14:49 RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy
• 13:17 Ultragenyx Wins First Sanfilippo Approval As Analyst Keeps Ratings Modest
• 12:34 Canaccord Genuity Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $39
• 11:28 Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?
• 09:41 Cantor Fitzgerald Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $39
• 06:18 Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of FAYUVI as First Treatment for Sanfilippo Syndrome Type A Transcript
• 04:26 Ultragenyx Pharmaceutical (RARE) Stock Jumps After Hours: Here's Why It Is Trending

RAREの取引アプリ

Adaptive Xauusd for Brokers and Prop Firms Full

Mauro Mazzacco

エキスパート

PRB Prime Range Breakout Professional MetaTrader 5 向けプロフェッショナル・ブレイクアウト取引および統計分析プラットフォーム PRB は、自動ブレイクアウト執行、高度なリスク管理、統計分析を1つのプロフェッショナルな取引プラットフォームに統合しています。 本システムは、取引ロジックを安定させたまま、過去のパフォーマンスを評価し、客観的なデータに基づいてポジションサイズを判断できるよう設計されています。 戦略そのものを頻繁に変更するのではなく、PRB は各セットアップが大規模かつ代表性のあるデータの中でどのように機能したかを分析します。執行ロジックは維持され、ユーザーは統計的根拠に応じてエクスポージャーを調整できます。 プロフェッショナル取引エンジン PRB は以下を自動で実行します。 Prime Range の検出 確認済みブレイクアウト機会の識別 最終 Stop Loss 距離に基づくロット計算 Stop Loss と Take Profit の管理 Break-even と Trailing Stop 口座保護ルールの適用 ブローカ

399 USD

Ultimate Nexus Point Reversal

Mushfiq Faysal

インディケータ

I'm not here to sell you dreams or promise you'll quit your job next month. This indicator identifies three proprietary patterns that 99% of traders have never seen before. Why? Because I discovered them myself and spent countless hours refining the detection algorithm to only show you the absolute best setups. I've included 11 real chart screenshots across different assets. Go ahead—try to spot these patterns yourself. If you can identify them without the indicator, then congratulations. You ha

133 USD

Nasdaq Heist Robot

Teboho Moses Tefo

エキスパート

This EA is used to trade Nas100 /nasdaq 100 index once a day every day at time 16:30 +3gmt(depends on broker server time) during NYSE, it is coded with intelligent money management feature to recover every single loss it made, but the loss can not be recovered on the same day, this EA is coded with the unique strategy to spot the direction of NASDAQ 100 during NYSE opening at.  PLEASE FIND SETTINGS UNDER SCREENSSHOTS, DONT USE DEFAULT SETTINGS! CONTACT WATSAPP FOR PROPER SETTINGS ( +277 2067 743

500 USD

Ideal Arrow Signal Pro

Yaroslav Varankin

インディケータ

This tool has proven itself well when tested on the Forex market on the EUR/USD currency pair. We also tested this tool for Binary Options and was able to show good quality signals on the EUR/USD currency exchange. SIGNALS DO NOT RENDERY MOVE THE ARROW BY 1 CANDLE MAXIMUM THIS IS EXTREMELY RARE TO ENCOUNTER  The signals of this instrument are formed during the candlestick. It is worth entering the trade after closing the candle on which the signal was generated. The green arrow indicates the po

100 USD